Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

The critical role of the PE21 element in oncostatin M-mediated transcriptional repression of the p53 tumor suppressor gene in breast cancer cells

Abstract

Cytokine oncostatin M (OM) exerts growth-inhibitory and differentiative effects on breast cancer cells. Previously we showed that the transcription from the p53 gene in breast cancer cells was down regulated by OM. To elucidate the molecular mechanisms underlying the OM effect on p53 transcription, in this study, we dissected the p53 promoter region and analysed the p53 promoter activity in breast tumor cells. We showed that treatment of MCF-7 cells with OM induced a dose- and time-dependent suppression of p53 promoter activity. The p53 promoter activity was decreased to 35% of control at 24 h and further decreased to 20% at 48 h by OM at concentrations of 5 ng/ml and higher. Deletion of the 5′-flanking region of the p53 promoter from −426 to −97 did not affect the OM effect. However, further deletion to −40 completely abolished the repressive effect of OM. The p53 promoter region −96 to −41 contains NF-κB and c-myc binding sites, and a newly identified UV-inducible element PE21. Mutations to disrupt NF-κB binding or c-myc binding to the p53 promoter decreased the basal promoter activity without affecting the OM-mediated suppression, whereas mutation at the PE21 motif totally abolished the OM effect. We further demonstrated that insertion of PE21 element upstream of the thymidine kinase minimal promoter generated an OM response analogous to that of the p53 promoter. Finally, we detected the specific binding of a nuclear protein with a molecular mass of 87 kDa to the PE21 motif. Taken together, we demonstrate that OM inhibits the transcription of the p53 gene through the PE21 element. Thus, the PE21 element is functionally involved in p53 transcription regulated by UV-induction and OM suppression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

Abbreviations

EMSA:

electrophoretic mobility shift assay

FBS:

fetal bovine serum

LIF:

leukemia inhibitory factor

OM:

oncostatin M

TK:

thymidine kinase

References

  • Balint E, Reisman D . 1996 Cancer Research 56: 1648–1653

  • Benoit V, Hellin A, Huygen S, Gielen J, Bours V, Merville M . 2000 Oncogene 19: 4787–4794

  • Briggs J, Kudlow J, Kraft A . 1996 J. Biol. Chem. 271: 901–906

  • Datto M, Yu Y, Wang X . 1995 J. Biol. Chem. 270: 28623–28628

  • Douglas A, Goss A, Sutherland R, Hilton D, Berndt M, Nicola N, Begley C . 1997 Oncogene 14: 661–669

  • Douglas A, Grant S, Goss G, Clouston D, Sutherland R, Begley C . 1998 Int. J. Cancer 75: 64–73

  • Estrov Z, Samal B, Kellokumpulehtinen P, Sahin AA, Kurzrock R, Talpaz M, Aggarwal BB . 1995 J. Interferon Cytokine Res. 15: 905–913

  • Hirose Y, Berger M, Pieper R . 2001 Cancer Research 61: 1957–1963

  • Horn D, Fitzpatrick W, Gompper P, Ochs V, Bolton-Hanson M, Zarling J, Malik N, Todaro G, Linsley P . 1990 Growth Factors 2: 157–165

  • Huang L, Sowa Y, Sakai T, Bpardee A . 2000 Oncogene 19: 5712–5719

  • Ito A, Lai C, Zhao X, Saito S, Hamilton M, Appella E, Yao T . 2001 EMBO J. 20: 1331–1340

  • Jeffy B, Chen E, Gudas J, Romagnolo D . 2000 Neoplasia 2: 460–470

  • Kao S, Lemoine F, Marriott S . 2000 J. Biol. Chem. 275: 35926–35931

  • Kirch H-C, Flaswinkel S, Rumpf H, Brockmann D, Esche H . 1999 Oncogene 18: 2728–2738

  • Lee M, Song H, Park S, Park J . 1998 Biol. Chem. 379: 1333–1340

  • Lee M, Song H, Yu S, Lee K, Park J . 1999 Biochem. Cell. Biol. 77: 209–214

  • Lee S, Rho H . 2000 Oncogene 19: 468–471

  • Liu J, Spence M, Wallace P, Forcier K, Hellstrom I, Vestal R . 1997 Cell. Growth Differ. 8: 667–676

  • Liu J, Li C, Ahlborn T, Spence M, Meng L, Boxer L . 1999 Cell. Growth Differ. 5: 15–18

  • Liu J, Ahlborn T, Briggs M, Kraemer F . 2000 J. Biol. Chem. 275: 5214–5221

  • Mokdad-Gargouri R, Belhadj K, Gargouri A . 2001 Nucleic Acids Res. 29: 1222–1227

  • Nakano K, Balint E, Ashcroft M, Vousden K . 2000 Oncogene 19: 4283–4289

  • Nakano K, Mizuno T, Sowa Y, Orita T, Okuyama Y, Fujita T, Ohtani F, Matsukawa Y, Tokino T . 1997 J. Biol. Chem. 272: 22199–22206

  • Nayak B, Das B . 1999 Mol. Biol. Rep. 26: 223–230

  • Noda A, Toma-Aiba Y, Fujiwaba Y . 2000 Oncogene 19: 21–31

  • Phan SC, Feeley B, Withers D, Boxer LM . 1996 Mol. Cell. Biol. 16: 2387–2393

  • Peeper D, Dannenberg J, Riele H, Bernards R . 2001 Nat. Cell. Biol. 3: 198–203

  • Pei X, Nakanish Y, Takayama K, Bai F, Hara N . 1999 J. Biol. Chem. 274: 35240–35246

  • Raman V, Martensaen S, Reisman D, Evron E, Odenwald W, Faffee M, Sukumar S . 2000 Nature 405: 974–978

  • Reich N, Levine A . 1984 Nature 308: 199–201

  • Seluanov A, Gorbunova V, Falcovitz A, Sigal A, Milyavsky M, Zurer I, Shohat G, Goldfinger N . 2001 Mol. Cell. Biol. 21: 1552–1564

  • Soini Y, Kamel D, Nuorva K, Lane D, Vahakangsa K . 1992 Pathol. Anat. Histopathol. 421: 415–420

  • Sowa Y, Orita T, Minamikawa S, Nakano K, Mizuno T, Normura H, Sakai T . 1997 Biochem. Biophys. Res. Comm. 241: 142–150

  • Spence M, Vestal R, Liu J . 1997 Cancer Research 57: 2223–2228

  • Stuart E, Haffner R, Oren M, Gruss P . 1995 EMBO J. 14: 5638–5645

  • Tuck S, Craword L . 1989 Mol. Cell. Biol. 9: 2163–2172

  • Uberti D, Grilli M . 2000 Amino Acids 19: 253–261

  • Wang J, Friedman E . 2000 Mol. Carcinog. 29: 179–188

  • Wang X, Ongkeko W, Lau A, Leung K, Poon R . 2001 Cancer Research 61: 1598–1603

  • Xu D, Wang Q, Gruber A, Bjorkholm M, Chen Z, Zaid A, Selivanova G, Peterson C, Wiman K, Pisa P . 2000 Oncogene 19: 5123–5133

  • Zarling J, Shoyab M, Marquardt H, Hanson M, Lionbin M, Todaro G . 1986 Proc. Natl. Acad. Sci. USA 83: 9739–9743

  • Zeng X, Keller D, Wu L, Lu H . 2000 Cancer Research 60: 6184–6188

  • Zhu Q, Wani M, El-Mahdy M, Wani G, Wanni A . 2000 Mol. Carcinog. 28: 215–224

Download references

Acknowledgements

This study was supported by the Department of Veterans Affairs (Office of Research and Development, Medical Research Service), by grant (1RO1CA83648-01) from National Cancer Institute, and by grant (BC990960) from the United States Army Medical Research and Development Command.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jingwen Liu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, C., Ahlborn, T., Tokita, K. et al. The critical role of the PE21 element in oncostatin M-mediated transcriptional repression of the p53 tumor suppressor gene in breast cancer cells. Oncogene 20, 8193–8202 (2001). https://doi.org/10.1038/sj.onc.1205046

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205046

Keywords

This article is cited by

Search

Quick links